The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users

@article{Jones2016TheEO,
  title={The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users},
  author={J. Jones and M. Sullivan and J. Manubay and S. Mogali and S. Comer},
  journal={Physiology & Behavior},
  year={2016},
  volume={159},
  pages={33-39}
}
  • J. Jones, M. Sullivan, +2 authors S. Comer
  • Published 2016
  • Medicine
  • Physiology & Behavior
    • AIMS Activation of PPARγ by pioglitazone (PIO) has shown some efficacy in attenuating addictive-like responses in laboratory animals. The ability of PIO to alter the effects of opioids in humans has not been characterized in a controlled laboratory setting. The proposed investigation sought to examine the effects of PIO on the subjective, analgesic, physiological and cognitive effects of oxycodone (OXY). METHODS During this investigation, nondependent prescription opioid abusers (N=17… CONTINUE READING
    View on Elsevier
    europepmc.org
    15 Citations
    Highly Influential Citations
    2
    Background Citations
    4
    Methods Citations
    2
    Results Citations
    1

    Figures, Tables, and Topics from this paper

    Figures and Tables

    Explore Further: Topics Discussed in This Paper

    15 Citations
    Citation Type

    Citation Type

    The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety
    • 9
    Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone
    • 4
    Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder
    • 8
    PPARγ activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle study
    • 1
    Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Substance Use Disorders: A Synthesis of Preclinical and Human Evidence
    • 3
    • Highly Influenced
    • PDF
    Endogenous Opiates and Behavior: 2016
    • 34
    Clinical Trials for Opioid Use Disorder.
    Drugs of Abuse Induced-Subversion of the Peripheral Immune Response and Central Glial Activity: Focus on Novel Therapeutic Approaches.
    • 1
    Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence
    • 26
    • PDF
    Potential of Glial Cell Modulators in the Management of Substance Use Disorders

    References

    SHOWING 1-10 OF 93 REFERENCES
    Activation of PPARγ by pioglitazone potentiates the effects of naltrexone on alcohol drinking and relapse in msP rats.
    • 55
    The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.
    • 125
    Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers.
    • 52
    • PDF
    Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers
    • 123
    Activation of Nuclear PPARγ Receptors by the Antidiabetic Agent Pioglitazone Suppresses Alcohol Drinking and Relapse to Alcohol Seeking
    • 100
    PPARγ Activation Attenuates Opioid Consumption and Modulates Mesolimbic Dopamine Transmission
    • 16
    PPARc Activation Attenuates Opioid Consumption and Modulates Mesolimbic Dopamine Transmission
    • 27
    • PDF
    Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course.
    • 32
    Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers.
    • 60
    • PDF
    Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)
    • 192
    • Highly Influential